JOHN ABALLI, the President and CEO of $XGN, sold 31,787 shares of the company on 10-16-2025 for an estimated $375,598. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their shares of this class of stock. Following this trade, they now own 714,427 shares of this class of $XGN stock.
$XGN Insider Trading Activity
$XGN insiders have traded $XGN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $XGN stock by insiders over the last 6 months:
- JOHN ABALLI (President and CEO) sold 31,787 shares for an estimated $375,598
- JEFFREY G. BLACK (Chief Financial Officer) sold 20,466 shares for an estimated $200,362
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XGN Hedge Fund Activity
We have seen 38 institutional investors add shares of $XGN stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. added 718,782 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,017,098
- WEXFORD CAPITAL LP added 416,348 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,906,109
- UBS GROUP AG added 383,691 shares (+613.7%) to their portfolio in Q2 2025, for an estimated $2,678,163
- RUSSELL INVESTMENTS GROUP, LTD. added 220,616 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,539,899
- FOURWORLD CAPITAL MANAGEMENT LLC added 208,527 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,455,518
- PERKINS CAPITAL MANAGEMENT INC removed 191,113 shares (-45.2%) from their portfolio in Q2 2025, for an estimated $1,333,968
- VANGUARD GROUP INC added 190,675 shares (+38.8%) to their portfolio in Q2 2025, for an estimated $1,330,911
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$XGN Analyst Ratings
Wall Street analysts have issued reports on $XGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 10/14/2025
- B. Riley Securities issued a "Buy" rating on 09/11/2025
- Canaccord Genuity issued a "Buy" rating on 07/30/2025
- Craig-Hallum issued a "Buy" rating on 07/23/2025
- Cantor Fitzgerald issued a "Overweight" rating on 05/15/2025
To track analyst ratings and price targets for $XGN, check out Quiver Quantitative's $XGN forecast page.
$XGN Price Targets
Multiple analysts have issued price targets for $XGN recently. We have seen 5 analysts offer price targets for $XGN in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Paul Knight from Keybanc set a target price of $15.0 on 10/14/2025
- Anderson Schock from B. Riley Securities set a target price of $15.0 on 09/11/2025
- Kyle Mikson from Canaccord Genuity set a target price of $11.0 on 07/30/2025
- John Wilkin from Craig-Hallum set a target price of $12.0 on 07/23/2025
- Ross Osborn from Cantor Fitzgerald set a target price of $7.0 on 05/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
